Skip to main content
BrainCited

N-Acetyl Cysteine لـ Post-Concussion Cognitive Symptoms

B

NAC demonstrated neuroprotective effects in traumatic brain injury models. MRI studies showed improvements in resting-state brain connectivity in mild TBI patients receiving NAC treatment.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dn\u002Dacetyl\u002Dcysteine\u0026condition\u003Dpost\u002Dconcussion'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

الخلاصة

NAC demonstrated neuroprotective effects in traumatic brain injury models. MRI studies showed improvements in resting-state brain connectivity in mild TBI patients receiving NAC treatment.

Key Study Findings

Randomized Controlled Trial n=50 Open-label
Changes in Resting-State Functional Connectivity and Cognitive-Affective Symptoms in Patients With Post-Concussion Syndrome Treated With …
Dose: None مقابل: waitlist control (standard of care) Outcome: resting-state functional connectivity and cognitive-affective symptoms التأثير: None p<0.05

المجتمع المدروس: patients with chronic post-concussion syndrome for at least 3 months

Review
Mitigating Traumatic Brain Injury: A Narrative Review of Supplementation and Dietary Protocols.
Dose: None مقابل: None Outcome: TBI prevention and neuroprotection التأثير: None None

المجتمع المدروس: Individuals with or at risk for TBI

Controlled Clinical Trial n=65 4 weeks Open-label
N -acetylcysteine is associated with reduction of postconcussive symptoms in elderly patients: A pilot study.
Dose: None مقابل: Standard care alone Outcome: RPQ postconcussion symptom severity التأثير: RPQ day 7: 2 vs 10; day 30: 0 vs 4 p=0.004 (day 7); p=0.021 (day

المجتمع المدروس: Elderly patients (>=60y) with mild TBI

Review
Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: restless legs syndrome

Review
Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: None

Review
Dietary Supplements for Health, Adaptation, and Recovery in Athletes.
Dose: None مقابل: None Outcome: Health, adaptation, and recovery in athletes التأثير: None None

المجتمع المدروس: Athletes

Key Statistics

6

الدراسات

400

المشاركون

Positive

B

التقييم

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
600-1,800 mg/day
neuroprotection:
1,200-2,400 mg/day

الحد الأعلى: Not established as supplement; 6,000+ mg/day used clinically (IV)

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Positive 50
None -- Positive --
None 4 weeks Positive 65
None -- Mixed --
None -- Positive --
None -- Mixed --
NAC 100 mg/kg body weight orally daily for 14 days 2 weeks Positive 24
None -- Mixed --

أفضل وقت للتناول: On empty stomach; split into 2-3 doses; supplement zinc if using long-term

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Nausea and vomiting
  • Diarrhea
  • Unpleasant sulfur taste/smell
  • Rare: bronchospasm (inhaled form)
  • Long-term use may deplete zinc stores

التفاعلات المعروفة

  • Nitroglycerin (may enhance hypotensive effects)
  • Activated charcoal (reduces NAC absorption)
  • Anticoagulants (theoretical interaction)

الحد الأقصى المسموح به: Not established as supplement; 6,000+ mg/day used clinically (IV)

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does N-Acetyl Cysteine help with Post-Concussion Cognitive Symptoms?
Based on 6 studies with 400 participants, there is moderate evidence from clinical studies that N-Acetyl Cysteine may support Post-Concussion Cognitive Symptoms management. Our evidence grade is B (Good Evidence).
How much N-Acetyl Cysteine should I take for Post-Concussion Cognitive Symptoms?
Studies have used various dosages. A commonly studied range is 600-1,800 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of N-Acetyl Cysteine?
Reported side effects may include Nausea and vomiting, Diarrhea, Unpleasant sulfur taste/smell, Rare: bronchospasm (inhaled form). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for N-Acetyl Cysteine and Post-Concussion Cognitive Symptoms?
We rate the evidence as Grade B (Good Evidence). This rating is based on 6 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.